ContraFect (CFRX) Announces First Gram-negative Product Candidate CF-370, Direct Lytic Agent Targeting Pseudomonas aeruginosa - StreetInsider.com

ContraFect (CFRX) Announces First Gram-negative Product Candidate CF-370, Direct Lytic Agent Targeting Pseudomonas aeruginosa  StreetInsider.com

Comments

Popular posts from this blog

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic